Logo image of IMCD.AS

IMCD NV (IMCD.AS) Stock Fundamental Analysis

Europe - AMS:IMCD - NL0010801007 - Common Stock

88.99 EUR
-0.83 (-0.92%)
Last: 10/17/2025, 11:40:44 AM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to IMCD. IMCD was compared to 15 industry peers in the Trading Companies & Distributors industry. While IMCD has a great profitability rating, there are some minor concerns on its financial health. IMCD is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

IMCD had positive earnings in the past year.
IMCD had a positive operating cash flow in the past year.
IMCD had positive earnings in each of the past 5 years.
In the past 5 years IMCD always reported a positive cash flow from operatings.
IMCD.AS Yearly Net Income VS EBIT VS OCF VS FCFIMCD.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

1.2 Ratios

IMCD has a Return On Assets of 5.76%. This is in the better half of the industry: IMCD outperforms 80.00% of its industry peers.
The Return On Equity of IMCD (13.50%) is better than 86.67% of its industry peers.
IMCD has a better Return On Invested Capital (8.81%) than 80.00% of its industry peers.
IMCD had an Average Return On Invested Capital over the past 3 years of 9.57%. This is in line with the industry average of 7.79%.
Industry RankSector Rank
ROA 5.76%
ROE 13.5%
ROIC 8.81%
ROA(3y)7.11%
ROA(5y)6.42%
ROE(3y)16.08%
ROE(5y)14.41%
ROIC(3y)9.57%
ROIC(5y)8.66%
IMCD.AS Yearly ROA, ROE, ROICIMCD.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

IMCD has a Profit Margin of 5.54%. This is in the better half of the industry: IMCD outperforms 80.00% of its industry peers.
In the last couple of years the Profit Margin of IMCD has grown nicely.
IMCD's Operating Margin of 8.93% is amongst the best of the industry. IMCD outperforms 86.67% of its industry peers.
IMCD's Operating Margin has improved in the last couple of years.
IMCD has a Gross Margin of 22.48%. This is comparable to the rest of the industry: IMCD outperforms 46.67% of its industry peers.
In the last couple of years the Gross Margin of IMCD has grown nicely.
Industry RankSector Rank
OM 8.93%
PM (TTM) 5.54%
GM 22.48%
OM growth 3Y0.9%
OM growth 5Y6.54%
PM growth 3Y-0.83%
PM growth 5Y7.95%
GM growth 3Y1.7%
GM growth 5Y2.81%
IMCD.AS Yearly Profit, Operating, Gross MarginsIMCD.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so IMCD is still creating some value.
IMCD has more shares outstanding than it did 1 year ago.
IMCD has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, IMCD has an improved debt to assets ratio.
IMCD.AS Yearly Shares OutstandingIMCD.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
IMCD.AS Yearly Total Debt VS Total AssetsIMCD.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

IMCD has an Altman-Z score of 3.04. This indicates that IMCD is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 3.04, IMCD is doing good in the industry, outperforming 66.67% of the companies in the same industry.
The Debt to FCF ratio of IMCD is 8.11, which is on the high side as it means it would take IMCD, 8.11 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of IMCD (8.11) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.70 indicates that IMCD is somewhat dependend on debt financing.
IMCD has a Debt to Equity ratio of 0.70. This is in the lower half of the industry: IMCD underperforms 73.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 8.11
Altman-Z 3.04
ROIC/WACC1.38
WACC6.39%
IMCD.AS Yearly LT Debt VS Equity VS FCFIMCD.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 1.75 indicates that IMCD should not have too much problems paying its short term obligations.
The Current ratio of IMCD (1.75) is comparable to the rest of the industry.
IMCD has a Quick Ratio of 1.04. This is a normal value and indicates that IMCD is financially healthy and should not expect problems in meeting its short term obligations.
IMCD's Quick ratio of 1.04 is on the low side compared to the rest of the industry. IMCD is outperformed by 60.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.75
Quick Ratio 1.04
IMCD.AS Yearly Current Assets VS Current LiabilitesIMCD.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

4

3. Growth

3.1 Past

The earnings per share for IMCD have decreased by -7.17% in the last year.
The Earnings Per Share has been growing by 18.74% on average over the past years. This is quite good.
IMCD shows a small growth in Revenue. In the last year, the Revenue has grown by 6.09%.
Measured over the past years, IMCD shows a quite strong growth in Revenue. The Revenue has been growing by 11.94% on average per year.
EPS 1Y (TTM)-7.17%
EPS 3Y10.14%
EPS 5Y18.74%
EPS Q2Q%-23.63%
Revenue 1Y (TTM)6.09%
Revenue growth 3Y11.23%
Revenue growth 5Y11.94%
Sales Q2Q%-0.88%

3.2 Future

Based on estimates for the next years, IMCD will show a small growth in Earnings Per Share. The EPS will grow by 5.01% on average per year.
The Revenue is expected to grow by 4.92% on average over the next years.
EPS Next Y0%
EPS Next 2Y4.49%
EPS Next 3Y5.79%
EPS Next 5Y5.01%
Revenue Next Year2.37%
Revenue Next 2Y3.91%
Revenue Next 3Y4.54%
Revenue Next 5Y4.92%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
IMCD.AS Yearly Revenue VS EstimatesIMCD.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B
IMCD.AS Yearly EPS VS EstimatesIMCD.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 19.43, which indicates a rather expensive current valuation of IMCD.
66.67% of the companies in the same industry are more expensive than IMCD, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of IMCD to the average of the S&P500 Index (27.29), we can say IMCD is valued slightly cheaper.
IMCD is valuated correctly with a Price/Forward Earnings ratio of 13.36.
The rest of the industry has a similar Price/Forward Earnings ratio as IMCD.
The average S&P500 Price/Forward Earnings ratio is at 22.85. IMCD is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 19.43
Fwd PE 13.36
IMCD.AS Price Earnings VS Forward Price EarningsIMCD.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, IMCD is valued a bit more expensive than 66.67% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of IMCD indicates a slightly more expensive valuation: IMCD is more expensive than 60.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 24.61
EV/EBITDA 12.02
IMCD.AS Per share dataIMCD.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

The decent profitability rating of IMCD may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.04
EPS Next 2Y4.49%
EPS Next 3Y5.79%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.36%, IMCD has a reasonable but not impressive dividend return.
The stock price of IMCD dropped by -20.09% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
IMCD's Dividend Yield is a higher than the industry average which is at 2.74.
IMCD's Dividend Yield is comparable with the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 2.36%

5.2 History

The dividend of IMCD is nicely growing with an annual growth rate of 22.38%!
Dividend Growth(5Y)22.38%
Div Incr Years0
Div Non Decr Years0
IMCD.AS Yearly Dividends per shareIMCD.AS Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

IMCD pays out 47.63% of its income as dividend. This is a bit on the high side, but may be sustainable.
IMCD's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP47.63%
EPS Next 2Y4.49%
EPS Next 3Y5.79%
IMCD.AS Yearly Income VS Free CF VS DividendIMCD.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
IMCD.AS Dividend Payout.IMCD.AS Dividend Payout, showing the Payout Ratio.IMCD.AS Dividend Payout.PayoutRetained Earnings

IMCD NV

AMS:IMCD (10/17/2025, 11:40:44 AM)

88.99

-0.83 (-0.92%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)07-30 2025-07-30/bmo
Earnings (Next)11-06 2025-11-06
Inst Owners74.84%
Inst Owner ChangeN/A
Ins Owners1.7%
Ins Owner ChangeN/A
Market Cap5.26B
Analysts81.82
Price Target148.1 (66.42%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.36%
Yearly Dividend2.2
Dividend Growth(5Y)22.38%
DP47.63%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-7.4%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.68%
EPS NY rev (3m)-7.29%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.16%
Revenue NY rev (3m)-2.92%
Valuation
Industry RankSector Rank
PE 19.43
Fwd PE 13.36
P/S 1.09
P/FCF 24.61
P/OCF 21.93
P/B 2.66
P/tB N/A
EV/EBITDA 12.02
EPS(TTM)4.58
EY5.15%
EPS(NY)6.66
Fwd EY7.48%
FCF(TTM)3.62
FCFY4.06%
OCF(TTM)4.06
OCFY4.56%
SpS81.49
BVpS33.42
TBVpS-10.16
PEG (NY)N/A
PEG (5Y)1.04
Profitability
Industry RankSector Rank
ROA 5.76%
ROE 13.5%
ROCE 12.09%
ROIC 8.81%
ROICexc 9.3%
ROICexgc 39.47%
OM 8.93%
PM (TTM) 5.54%
GM 22.48%
FCFM 4.44%
ROA(3y)7.11%
ROA(5y)6.42%
ROE(3y)16.08%
ROE(5y)14.41%
ROIC(3y)9.57%
ROIC(5y)8.66%
ROICexc(3y)10.67%
ROICexc(5y)9.54%
ROICexgc(3y)40.09%
ROICexgc(5y)35.52%
ROCE(3y)14.12%
ROCE(5y)13.14%
ROICexcg growth 3Y11.47%
ROICexcg growth 5Y12.83%
ROICexc growth 3Y2.19%
ROICexc growth 5Y4.08%
OM growth 3Y0.9%
OM growth 5Y6.54%
PM growth 3Y-0.83%
PM growth 5Y7.95%
GM growth 3Y1.7%
GM growth 5Y2.81%
F-Score5
Asset Turnover1.04
Health
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 8.11
Debt/EBITDA 2.41
Cap/Depr 18.63%
Cap/Sales 0.54%
Interest Coverage 6.84
Cash Conversion 42.06%
Profit Quality 80.16%
Current Ratio 1.75
Quick Ratio 1.04
Altman-Z 3.04
F-Score5
WACC6.39%
ROIC/WACC1.38
Cap/Depr(3y)23.75%
Cap/Depr(5y)23.21%
Cap/Sales(3y)0.62%
Cap/Sales(5y)0.61%
Profit Quality(3y)103.46%
Profit Quality(5y)114.83%
High Growth Momentum
Growth
EPS 1Y (TTM)-7.17%
EPS 3Y10.14%
EPS 5Y18.74%
EPS Q2Q%-23.63%
EPS Next Y0%
EPS Next 2Y4.49%
EPS Next 3Y5.79%
EPS Next 5Y5.01%
Revenue 1Y (TTM)6.09%
Revenue growth 3Y11.23%
Revenue growth 5Y11.94%
Sales Q2Q%-0.88%
Revenue Next Year2.37%
Revenue Next 2Y3.91%
Revenue Next 3Y4.54%
Revenue Next 5Y4.92%
EBIT growth 1Y5.06%
EBIT growth 3Y12.24%
EBIT growth 5Y19.26%
EBIT Next Year21.47%
EBIT Next 3Y11.62%
EBIT Next 5Y13.77%
FCF growth 1Y-45.22%
FCF growth 3Y12.49%
FCF growth 5Y10.07%
OCF growth 1Y-42.37%
OCF growth 3Y12.47%
OCF growth 5Y9.9%